Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC Keeping it real board for pro and con discussions -- Ignore unavailable to you. Want to Upgrade?

To: drkaz who wrote (89)	2/1/2015 9:29:35 PM
From: Rawnoc	Respond to of 326

Message 29923063 If that's not bait I don't know what is. ROFL!! I can't imagine anybody "reflecting" to themselves "darn, I shouldn't have said mean things about a POS stock on the internet." lol After NNVC is dead and buried, you will have the rest of your life to reflect on it. I just hope for your own financial means, and sanity, that you didn't invest more than you can afford to lose. As for me, I'll only reflect on it for the laugh. I've rarely seen a promotion as silly as this cure-all snake oil crap. I once had a biowreck that I lost my ass on and couldn't believe afterwards that I really fell for it. But this promotion takes the cake.

To: drkaz who wrote (89)	2/4/2015 6:43:47 PM
From: Rawnoc	Read Replies (1) \| Respond to of 326

FINRA ISSUES DIRE WARNING ABOUT VIRUS STOCK SCAMS. FINRA Warns Investors of Viral Disease Stock Scams WASHINGTON—The Financial Industry Regulatory Authority (FINRA) issued a new Investor Alert called Viral Disease Stock Scams: Don't Let Them Infect Your Portfolio warning investors of promotions touting stocks in companies that claim to provide products that protect against the spread of viruses or other harmful diseases. FINRA is aware of several potential investment scams involving companies that claim to be involved in the development of products that will prevent the spread of viral diseases. "News coverage of Ebola and Middle East Respiratory Syndrome (MERS) is likely to catch the interest of 'pump and dump' scammers looking to capitalize on fears of a potential pandemic," said Gerri Walsh, FINRA's Senior Vice President for Investor Education. "Investors should be very cautious of any company that claims it is poised for dramatic growth as a result of a purported cure or treatment for high-profile viral diseases." Viral Disease Stock Scams provides investors with a list of tips to avoid potential stock scams. Consider the source. Be skeptical of press releases, emails and promotional materials from unknown senders hyping a company and its products. Do some sleuthing. Find out who is at the controls of a company before you invest. Be wary of frequent changes to a company's name or business focus. Frequent name changes may be a sign that a company is engaged in a potential fraud. Don't fall for name dropping. Citing a relationship with a government agency, prominent company or academic institution may be a ploy to create legitimacy for a company that does not deserve it. Investors who receive an offer that contains exaggerated or misleading claims are urged to contact FINRA. FINRA, the Financial Industry Regulatory Authority, is the largest independent regulator for all securities firms doing business in the United States. FINRA is dedicated to investor protection and market integrity through effective and efficient regulation and complementary compliance and technology-based services. FINRA touches virtually every aspect of the securities business – from registering and educating all industry participants to examining securities firms, writing rules, enforcing those rules and the federal securities laws, informing and educating the investing public, providing trade reporting and other industry utilities, and administering the largest dispute resolution forum for investors and firms. For more information, please visit www.finra.org. finra.org